- Journal List
- Arthroplast Today
- v.27; 2024 Jun
- PMC11282420
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice
Arthroplast Today. 2024 Jun; 27: 101393.
Published online 2024 May 11. doi:10.1016/j.artd.2024.101393
PMCID: PMC11282420
PMID: 39071820
Alana Prinos, BS,∗ Weston Buehring, MHS, BS, Catherine Di Gangi, BS, Patrick Meere, MD, Morteza Meftah, MD, and Matthew Hepinstall, MD
Author information Article notes Copyright and License information PMC Disclaimer
Associated Data
- Supplementary Materials
Abstract
Background
The utilization of technology, including robotics and computer navigation, in total hip arthroplasty (THA) has been steadily increasing; however, conflicting data exists regarding its effect on short-term clinical and patient-reported outcomes. Therefore, this study sought to explore the association between different surgical technologies and postoperative outcomes following THA.
Methods
We retrospectively reviewed 9892 primary THA cases performed by 62 surgeons from a single institution from September 2017 to November 2022. Three cohorts were created based on the utilization of technology: conventional (no technology), navigation, or robotics. Patient demographics, clinical outcomes, and patient-reported outcome measures were collected over the first 90 days following surgery. This data was compared using analysis of variance and multivariate logistic regressions. In total, 4275 conventional, 4510 navigation, and 1107 robotic cases were included in our analyses.
Results
The robotic cohort achieved a perfect Activity Measure for Post-Acute Care (AM-PAC) score earliest (0.1 days, P < .001). After adjusting for potential confounding variables, use of robotic assistance was associated with greater odds of achieving a perfect AM-PAC score on postoperative day 0 (odds ratio 1.6, P < .001) and greater odds of having length of stay shorter than 24 hours (odds ratio 2.3, P < .001) compared to no technology use in THA. Hip dysfunction and Osteoarthritis Outcome Score, Joint Replacement and Patient-Reported Outcomes Measurement Information System Pain Interference scores showed the greatest improvement in the robotic cohort at both 6 weeks and 3 months following surgery.
Conclusions
The present study demonstrates favorable clinical and patient-reported outcomes in the first 90 days following surgery for patients undergoing robot-assisted THA compared to conventional and navigation-assisted THA.
Keywords: Total hip arthroplasty, Technology, Robot, Computer navigation, Outcomes, Patient-reported outcome measures
Introduction
Total hip arthroplasty (THA) can reduce pain, restore function, and enhance the quality of life for patients suffering from a variety of degenerative, developmental, and traumatic hip joint disorders [1,2]. Nevertheless, the opportunity remains to reduce the already low incidence of mechanical complications related to bone preparation and component positioning, such as fixation failure, aseptic loosening, and instability [3]. Advancements in surgical techniques and technologies continue to transform the landscape of hip arthroplasty practices. While traditional manually-instrumented techniques often achieve excellent results, computer-assisted navigation and robotic assistance have been introduced to minimize failures and increase postoperative success.
Previous studies have described superior radiographic findings when intraoperative technology is utilized in THA [[4], [5], [6], [7], [8]]. Improved accuracy and precision of implant positioning have been postulated to contribute to enhanced long-term patient outcomes, reduced complications, and an overall improvement in the functional and radiographic success of THA [5]. However, the question remains whether observed improvements are indeed attributable to the use of technology or rather have occurred as a product of confounding factors such as improved surgeon practices, techniques, or hospital policies and procedures.
As surgical techniques are refined and perfected, there is an increasing demand for immediate and reliable solutions for advanced hip disease. Patients are becoming more adept at investigating their own diagnoses and anticipated outcomes, and both patients and surgeons seek to understand the elements of the THA procedure that contribute to improved outcomes during the initial recovery. Hospitals and payers are particularly focused on outcomes in the first 90 days, which are markedly impacted by both patient and surgical characteristics.
Currently, conflicting data exists regarding whether the use of intraoperative technology, in the form of computer-assisted navigation and robotic assistance in THA, does indeed provide improved short-term outcomes [[9], [10], [11]]. Sequential cohort studies of new surgical techniques can be influenced by confounding variables that demonstrate time-dependent improvements, such as surgical team and institutional processes. We sought to design a retrospective study that would minimize this bias by studying a large group of surgeons with nonuniform adoption of technology over the study period and by accounting for the year of surgery as a potential confounding variable. This allowed us to study the natural experiment of surgeon adoption and to control for improved institutional processes over the study duration as use of robotic and computer-navigated technology increased. We therefore reviewed our institutional database to examine the hypothesis that the use of specific intraoperative technologies during THA results in faster recovery and superior clinical and patient-reported 90-day outcomes when compared to traditional manually-instrumented techniques.
Material and methods
Study population
Following institutional review board approval, a retrospective cohort of 9892 patients was identified who underwent primary total hip arthroplasty (pTHA) at a large academic medical center from September 20, 2017—when the current system for electronic patient-reported outcome measure (PROM) data collection was introduced—to November 28,2022.
This study population was divided into 3 cohorts based on intraoperative technology utilization: conventional (no technology utilized, n= 4275), computer navigation-assisted (n= 4510), and robotic-assisted (n= 1107). Sixty-two surgeons were included in the study: 59 in the conventional cohort, 18 in the robotic cohort, and 34 in the navigation cohort. Thirty-seven of the 62 surgeons performed surgeries in more than one cohort, and 12 surgeons performed surgeries in all 3 cohorts. Twenty surgeons performed both conventional and navigation-assisted THA; 4 performed both conventional and robotic-assisted THA; and one performed both robotic and navigation-assisted THA. In this large retrospective study, many surgeons used multiple surgical techniques for THA over the course of the study period in response to evolving research and practice trends. Patient data was extracted from the electronic medical record system (Epic Systems Corporation, Verona, WI). Patients were excluded if they received a hip hemiarthroplasty or revision hip arthroplasty. Indications for pTHA included osteoarthritis, inflammatory arthritis, and avascular necrosis. Cases with oncologic or fracture diagnoses were excluded. The mean age of the patients in the conventional cohort was 66.1 (range 12-97), while the mean ages in the navigation and robotic cohorts were 63.1 (range 13-97) and 63.6 (range 18-91), respectively. The conventional cohort had the largest mean body mass index (BMI) of 29.6 kg/m2 (range 14.4-54.3), compared to 29.2 kg/m2 (range 14.9-58.4) in the navigation cohort and 29.3 kg/m2 (range 16.2-52.1) in the robotic cohort. There were no significant differences in sex (P= .217) between the 3 cohorts. Additional demographic data can be found in Table1.
Table1
Patient demographics.
Variable | Conventional (n= 4275) | Navigation (n= 4510) | Robotic (n= 1107) | P-value |
---|---|---|---|---|
Mean age, years (range) | 66.1 (12-97) | 63.1 (13-97) | 63.6 (18-91) | <.001 |
Mean BMI, kg/m2 (range) | 29.6 (14.3-54.3) | 29.2 (14.9-58.4) | 29.3 (16.2-52.1) | .021 |
Women, n (%) | 2402 (56.2) | 2599 (57.6) | 611 (55.2) | .217 |
Race, n (%) | <.001 | |||
White | 3312 (77.5) | 3116 (69.1) | 881 (79.6) | |
Black | 512 (12.0) | 684 (15.2) | 108 (9.8) | |
Asian | 72 (1.7) | 112 (2.5) | 19 (1.7) | |
Other/unknown | 379 (8.9) | 598 (13.3) | 99 (8.9) | |
Smoking status, n (%) | .553 | |||
Never | 2212 (51.7) | 2410 (53.4) | 580 (52.4) | |
Former | 1727 (40.4) | 1726 (38.3) | 454 (41.0) | |
Current | 320 (7.5) | 363 (8.0) | 65 (5.9) | |
Insurance type, n (%) | <.001 | |||
Medicare | 2353 (55.0) | 1990 (44.1) | 483 (43.6) | |
Medicaid | 326 (7.6) | 600 (13.3) | 90 (8.1) | |
Commercial | 1588 (37.1) | 1895 (42.0) | 531 (48.0) | |
Other | 8 (0.2) | 25 (0.6) | 9 (0.8) | |
ASA classification, n (%) | <.001 | |||
1 | 205 (4.8) | 402 (8.9) | 83 (7.5) | |
2 | 2323 (54.3) | 2870 (63.6) | 680 (61.4) | |
3 | 1665 (38.9) | 1175 (26.1) | 334 (30.2) | |
4 | 82 (1.9) | 63 (1.4) | 3 (0.3) | |
Mean CCI ± standard deviation | 3.7 ± 2.6 | 3.3 ± 2.6 | 3.3 ± 2.5 | <.001 |
Diagnosis, n (%) | <.001 | |||
Osteoarthritis | 4045 (94.6) | 4313 (95.6) | 1065 (96.2) | |
Osteonecrosis | 145 (3.4) | 130 (2.9) | 30 (2.7) | |
Other | 85 (2.0) | 67 (1.5) | 12 (1.1) |
Open in a separate window
All bold P-values are statistically significant (P < .05).
Data collection
Chart review was conducted to collect patient demographics, surgical characteristics, clinical outcomes, and PROMs. Patient demographics collected included age, BMI, sex, race, smoking status, insurance type, American Society of Anesthesiology (ASA) score, Charlson comorbidity index (CCI) score [12], and preoperative diagnoses. Surgical characteristics collected included the type of technology used intraoperatively (no technology, imageless computer navigation, or computed tomography-based robotics), surgical approach, and year of surgery. Clinical outcomes collected immediately following surgeryincluded length of stay in the hospital and discharge disposition. The Activity Measure for Post-Acute Care (AM-PAC) “6-Clicks” mobility score is a postoperative prediction tool that measures a patient’s ability to transfer and mobilize after surgery [13]. Once a patient is medically stable, a perfect AM-PAC score of 24 indicates sufficient functional independence to imply readiness for discharge home. The AM-PAC score is part of a holistic assessment of discharge readiness, such that patients with more assistance at home can be safely discharged without a perfect score. Daily AM-PAC scores were recorded for the duration of each patient’s hospitalstay as well as the postoperative day on which patients achieved a perfect score. Readmissions within the first 90 days following surgery were recorded, along with reasons for readmission and the number of dislocations requiring revision within the first 90 days following surgery.
Two PROMs were collected: Hip dysfunction and Osteoarthritis Outcome Score, Joint Replacement (HOOS, JR.) and Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference scores. These PROMs were administered preoperatively as well as at 6 weeks and 3 months postoperatively as part of clinical care. Systematic administration of PROMs began at our institution during the study period, meaning that not all patients had scores available from preoperative and both postoperative time points. Preoperative and 6-week postoperative HOOS, JR. were both completed by 1699 patients, and preoperative and 3-month postoperative HOOS, JR. were both completed by 1387 patients. There were 2037 patients who completed both a preoperative and 6-week postoperative PROMIS Pain Interference score and 1862 patients who completed both a preoperative and 3-month postoperative PROMIS Pain Interference score.
Data analyses
The primary outcomes of this study were the postoperative day on which a perfect AM-PAC score was achieved and improvements in HOOS, JR. and PROMIS Pain Interference scores. Secondary outcomes included length of stay, discharge disposition, readmissions within the first 90 days following surgery, reason for readmission, and the rate of dislocation requiring revision in the first 90 days following surgery. Surgical characteristics and clinical and patient-reported outcomes were reported as either a mean with a range or standard deviation or as the number of cases with the percentage of total cases.
Analyses comparing patient demographics, clinical outcomes, and PROMs (HOOS, JR. and PROMIS Pain Interference) between the 3 cohorts: conventional, navigation, and robotic—were performed using one-way analysis of variance testing. Separate analyses were conducted for the preoperative to 6-week postoperative and preoperative to 3-month postoperative intervals, as PROMs were not available for all study time points in all patients. Post hoc testing was performed using the Fisher’s least significant difference test. A multivariable analysis was performed using binary logistic regression to assess the odds of achieving a perfect AM-PAC score on postoperative day 0 in relation to multiple characteristics, including use of technology and surgical approach. Additional demographic variables, including age at surgery, BMI, race, insurance type, ASA score, CCI score, and preoperative diagnosis were included in the multivariable analysis to control for differences in these variables between cohorts. The year of surgery was also included as a control variable because, due to changes in surgical team processes and administrative policy, length of stay and trends in discharge disposition have changed over the 5years that this study was performed. This variable was therefore included as a control to prevent new techniques from appearing artificially better than old techniques due to any evolving institutional norms. Additional multivariable analyses were performed to assess the odds of achieving length of stay shorter than 24 hours, the odds of readmission within 90 days following surgery, and the odds of dislocation requiring revision within 90 days following surgery in relation to technology use and surgical approach. The same variables (listed above) were included as controls in these analyses. Analyses were performed with the use of SPSS v25 (International Business Machines Corporation, Armonk, NY). The level of significance was set at a P-value of less than .05. This study was performed in accordance with the ethical standards of the institutional review board (study number i17-01,223_CR5) and the Helsinki Declaration.
Results
The mean lengths of stay in the hospital following surgery were longest for the conventional cohort (48.1 hours, range 7-728) and shortest for the robotic cohort (36.7 hours, range 6-469). The lengths of stay in each cohort were significantly different from each of the other cohorts, respectively (P < .001) (See Table2). A multivariable analysis was performed to assess the association between the use of technology and the likelihood of having a length of stay less than 24 hours. This regression accounted for potential confounding variables, including surgical approach, year of surgery, age at surgery, BMI, race, insurance type, ASA score, CCI score, and preoperative diagnosis. After adjusting for these variables, use of robotic assistance and navigation in pTHA were both associated with increased odds of achieving a length of stay shorter than 24 hours (odds ratio [OR] 2.3, P < .001 in robotics and OR 1.7, P < .001 in navigation) compared to no technology use in pTHA (see Table 3).
Table2
Immediate postoperative outcomes.
Variable | Conventional (n= 4275) | Navigation (n= 4510) | Robotic (n= 1107) | P-value |
---|---|---|---|---|
Mean LOS, hours (range) | 48.1 (7-728) | 40.9 (4-1308) | 36.7 (6-469) | <.001 |
Discharge disposition, n (%) | <.001 | |||
Home | 3857 (90.2) | 4212 (93.4) | 1066 (96.3) | |
Skilled nursing facility | 366 (8.6) | 246 (5.5) | 29 (2.6) | |
Other | 52 (1.2) | 52 (1.2) | 12 (1.1) | |
Mean day on which perfect AM-PAC score was achieved ± standard deviation | 0.5 ± 0.8 | 0.5 ± 0.9 | 0.1 ± 0.5 | <.001 |
Mean total score ± standard deviation | ||||
POD0 | 18.9 ± 3.3 | 20.8 ± 3.2 | 21.1 ± 3.3 | <.001 |
POD1 | 20.1 ± 3.8 | 21.2 ± 3.3 | 21.1 ± 3.2 | <.001 |
Open in a separate window
Variable | Conventional (n= 3515) | Navigation (n= 3483) | Robotic (n= 450) | P-value |
---|---|---|---|---|
Perfect AM-PAC score reached on day, n (%) | <.001 | |||
POD0 | 394 (11.2) | 858 (24.6) | 162 (36.0) | |
POD1 | 1039 (29.6) | 1137 (32.6) | 92 (20.4) | |
POD2 | 288 (8.2) | 312 (9.0) | 18 (4.0) | |
POD3 | 80 (2.3) | 103 (3.0) | 4 (0.9) | |
POD4≤ | 37 (1.1) | 49 (1.4) | 4 (0.9) | |
Never achieved | 1677 (47.7) | 1024 (29.4) | 170 (37.8) |
Open in a separate window
LOS, length of stay; POD, postoperative day.
All bold P-values are statistically significant (P < .05).
Table3
Multivariable analysis for length of stay <24 h odds ratio.
Variable | LOS<24 h odds ratio | P-value |
---|---|---|
Surgical technique | ||
Conventional | -- | |
Navigation | 1.7 (1.5-1.9) | <.001 |
Robot-assist | 2.3 (1.8-3.0) | <.001 |
THA approach | ||
Posterior | -- | |
Anterior | 3.1 (2.8-3.5) | <.001 |
Lateral | 1.2 (0.9-1.5) | .192 |
Year of surgery | ||
2017 | -- | |
2018 | 0.9 (0.7-1.2) | .487 |
2019 | 1.0 (0.7-1.4) | .882 |
2020 | 2.3 (1.7-3.2) | <.001 |
2021 | 3.0 (2.2-4.2) | <.001 |
2022 | 3.4 (2.5-4.7) | <.001 |
Age at surgery | 1.0 (1.0-2.0) | <.001 |
BMI | 1.0 (0.9-1.0) | <.001 |
Race | ||
White | -- | |
Black | 0.4 (0.3-0.5) | <.001 |
Asian | 0.6 (0.4-0.9) | .007 |
Other | 0.5 (0.4-0.6) | <.001 |
Insurance type | ||
Medicare | -- | |
Commercial | 2.1 (1.8-2.4) | <.001 |
Medicaid | 0.7 (0.6-1.0) | .022 |
Other | 0.1 (0.0-0.9) | .043 |
ASA | ||
1 | -- | |
2 | 0.5 (0.4-0.6) | <.001 |
3 | 0.2 (0.1-0.2) | <.001 |
4 | 0.1 (0.0-0.3) | <.001 |
CCI | 0.9 (0.9-1.0) | <.001 |
Diagnosis | ||
Osteoarthritis | -- | |
Osteonecrosis | 0.7 (0.5-1.0) | .060 |
Other | 0.2 (0.1-0.4) | <.001 |
Open in a separate window
LOS, length of stay.
All bold P-values are statistically significant (P < .05).
Of the 3 cohorts, robotics had the highest percentage of patients discharged home (96.3%), followed by navigation (93.4%) and conventional (90.2%). The discharge disposition in each cohort was significantly different from each of the other cohorts, respectively (P < .001) (see Table2).
The mean day on which a perfect AM-PAC score was achieved was earliest in the robotic cohort at 0.1 days, followed by the navigation and conventional cohorts, which were both 0.5 days (P < .001 between robotic and each of the other cohorts, respectively). The mean AM-PAC score on postoperative day 0 was the highest in the robotic cohort at 21.1, followed by the navigation cohort at 20.8, and the conventional cohort at 18.9. The mean AM-PAC score on postoperative day 0 in the robotic cohort was significantly greater than in the conventional cohort (P < .001) but not significantly different from the navigation cohort (P= .105). The robotic cohort had the greatest percentage of patients achieve a perfect score on postoperative day 0 (36.0%), followed by the navigation and conventional cohorts (24.6 and 11.2%, respectively). All 3 cohorts were significantly different from one another in the number of patients that achieved a perfect AM-PAC score on postoperative day 0 (P < .001) (see Table2).
A multivariable analysis was performed to assess the association between use of technology and the likelihood of achieving a perfect AM-PAC score on postoperative day 0, while accounting for the same potential confounding variables as stated above. After adjusting for these variables, use of robotic assistance and navigation in pTHA were both associated with greater odds of achieving a perfect AM-PAC score on postoperative day 0 compared to no technology use in pTHA (OR 1.6, P < .001 for robotics and OR 1.7, P < .001 for navigation) (See Table 4).
Table4
Multivariable analysis for perfect AM-PAC score achievement on POD0 odds ratio.
Variable | Perfect score POD0 odds ratio | P-value |
---|---|---|
Surgical technique | ||
Conventional | -- | |
Navigation | 1.7 (1.2-2.1) | <.001 |
Robot-assist | 1.6 (1.5-2.0) | <.001 |
THA approach | ||
Posterior | -- | |
Anterior | 2.8 (2.4-3.2) | <.001 |
Lateral | 1.1 (0.8-1.5) | .393 |
Year of surgery | ||
2017 | -- | |
2018 | 0.8 (0.6-1.2) | .265 |
2019 | 0.9 (0.6-1.3) | .482 |
2020 | 1.5 (1.1-2.2) | .018 |
2021 | 1.8 (1.3-2.5) | .001 |
2022 | 2.2 (1.6-3.1) | <.001 |
Age at surgery | 1.0 (1.0-1.0) | <.001 |
BMI | 1.0 (0.9-1.0) | <.001 |
Race | ||
White | -- | |
Black | 0.4 (0.3-0.5) | <.001 |
Asian | 0.8 (0.5-1.2) | .318 |
Other | 0.7 (0.6-0.9) | .005 |
Insurance type | ||
Medicare | -- | |
Commercial | 2.0 (1.6-2.3) | <.001 |
Medicaid | 0.8 (0.6-1.1) | .235 |
Other | 0.5 (0.1-2.2) | .358 |
ASA | ||
1 | -- | |
2 | 0.6 (0.5-0.8) | <.001 |
3 | 0.2 (0.1-0.3) | <.001 |
4 | 0.0 (0.0--) | .995 |
CCI | 0.9 (0.9-1.0) | <.001 |
Diagnosis | ||
Osteoarthritis | -- | |
Osteonecrosis | 0.8 (0.6-1.3) | .394 |
Other | 0.4 (0.2-0.9) | .026 |
Open in a separate window
POD, postoperative day.
All bold P-values are statistically significant (P < .05).
With the exception of 2017, the rate of readmissions was stable over the study period. Unexpectedly, there was a lower rate of readmission in 2017, which was a partial year with fewer cases included. The robotic cohort had the lowest rate of readmissions within the first 90 days following surgery (30 patients, 2.7%). This was significantly smaller than the 90-day readmission rate in both the conventional cohort (193 patients, 4.5%, P= .007) and the navigation cohort (182 patients, 4.0%, P= .046). In the multivariable analysis assessing the likelihood of readmission within 90 days following surgery, neither robotics nor navigation significantly impacted the odds of a 90-day readmission when compared to no technology use (OR 0.5, P= .055 for robotics and OR 1.0, P= .767 for navigation) (See Table5).
Table5
Multivariable analysis for readmission within 90 d odds ratio.
Variable | 90-D readmission odds ratio (CI) | P-value |
---|---|---|
Surgical technique | ||
Conventional | -- | |
Navigation | 1.0 (0.8-1.2) | .767 |
Robot-assist | 0.5 (0.3-1.0) | .055 |
THA approach | ||
Posterior | -- | |
Anterior | 0.7 (0.5-0.9) | .003 |
Lateral | 0.7 (0.5-1.2) | .250 |
Year of surgery | ||
2017 | -- | |
2018 | 1.9 (1.0-3.4) | .042 |
2019 | 1.6 (0.9-3.0) | .124 |
2020 | 1.8 (1.0-3.3) | .059 |
2021 | 1.8 (1.0-3.3) | .068 |
2022 | 1.6 (0.8-2.9) | .166 |
Age at surgery | 1.0 (1.0-1.0) | .119 |
BMI | 1.0 (1.0-1.0) | .033 |
Race | ||
White | -- | |
Black | 0.8 (0.6-1.1) | .127 |
Asian | 1.0 (0.4-2.1) | .956 |
Other | 1.0 (0.7-1.4) | .966 |
Insurance type | ||
Medicare | -- | |
Commercial | 0.8 (0.6-1.1) | .191 |
Medicaid | 1.2 (0.8-1.7) | .440 |
Other | 1.6 (0.4-7.1) | .508 |
ASA | ||
1 | -- | |
2 | 3.9 (1.6-9.6) | .003 |
3 | 5.8 (2.3-14.5) | <.001 |
4 | 9.9 (3.4-28.8) | <.001 |
CCI | 1.0 (1.0-1.1) | .063 |
Diagnosis | ||
Osteoarthritis | -- | |
Osteonecrosis | 1.3 (0.8-2.3) | .285 |
Other | 3.5 (2.1-5.8) | <.001 |
Open in a separate window
All bold P-values are statistically significant (P < .05).
The robotic cohort had no dislocations requiring revision within 90 days following surgery; the navigation cohort had 11 (0.2%); and the conventional cohort had 14 (0.3%). The 90-day rate of dislocation requiring revision was not significantly different between any of the 3 cohorts (P= .152) (See Table 6). The multivariate analysis assessing the likelihood of suffering a dislocation requiring revision in the first 90 days following surgery produced similar results, in that the use of neither robotics nor navigation in pTHA significantly impacted the odds of a dislocation requiring revision in the 90 days following surgery when compared to no technology use in pTHA (OR 0, P= .993 for robotics and OR 1.0, P= .931 for navigation) (See Table 7).
Table6
Short-term clinical outcomes.
Variable | Conventional (n= 4275) | Navigation (n= 4510) | Robotic (n= 1107) | P-value |
---|---|---|---|---|
90-D readmissions, n (%) | 193 (4.5) | 182 (4.0) | 30 (2.7) | .025 |
Reason for readmission, n (%) | .304 | |||
Dislocation/instability | 19 (0.4) | 15 (0.3) | 0 (0.0) | |
Infection (+wound/blood) | 42 (1.0) | 46 (1.0) | 8 (0.7) | |
Fracture | 27 (0.6) | 28 (0.6) | 3 (0.3) | |
Other | 105 (2.5) | 93 (2.1) | 19 (1.7) | |
90-D dislocations requiring revision, n (%) | 14 (0.3) | 11 (0.2) | 0 (0.0) | .152 |
Open in a separate window
All bold P-values are statistically significant (P < .05).
Table7
Multivariable analysis for dislocation requiring revision within 90 d odds ratio.
Variable | 90-D dislocation requiring revision odds ratio | P-value |
---|---|---|
Surgical technique | ||
Conventional | -- | |
Navigation | 1.0 (0.4-2.4) | .931 |
Robot-assist | 0.0 (0.0--) | .993 |
THA approach | ||
Posterior | -- | |
Anterior | 0.8 (0.3-2.0) | .602 |
Lateral | 0.5 (0.1-4.0) | .525 |
Year of surgery | ||
2017 | -- | |
2018 | 0.8 (0.2-4.2) | .818 |
2019 | 1.3 (0.3-6.3) | .752 |
2020 | 0.7 (0.1-3.8) | .644 |
2021 | 0.3 (0.0-2.4) | .277 |
2022 | 0.3 (0.0-2.2) | .231 |
Age at surgery | 1.0 (0.9-1.0) | .731 |
BMI | 1.0 (1.0-1.1) | .278 |
Race | ||
White | -- | |
Black | 0.2 (0.0-1.7) | .152 |
Asian | 2.0 (0.2-15.6) | .524 |
Other | 0.3 (0.0-2.3) | .249 |
Insurance type | ||
Medicare | -- | |
Commercial | 1.0 (0.3-2.9) | .994 |
Medicaid | 0.4 (0.0-3.2) | .363 |
Other | 0.0 (0.0--) | .998 |
ASA | ||
1 | -- | |
2 | 1.1 (0.1-9.4) | .902 |
3 | 1.8 (0.2-16.5) | .609 |
4 | 2.5 (0.1-52.0) | .564 |
CCI | 1.1 (0.9-1.2) | .436 |
Diagnosis | ||
Osteoarthritis | -- | |
Osteonecrosis | 1.5 (0.2-11.9) | .726 |
Other | 6.4 (1.4-29.3) | .016 |
Open in a separate window
All bold P-values are statistically significant (P < .05).
Among patients who had both preoperative and 6-week postoperative HOOS, JR. scores, the mean improvement in HOOS, JR. at the 6-week postoperative interval was greatest in the robotic cohort (20.3). This was significantly greater than the improvement in the navigation cohort (16.4, P= .020), but was not significantly different from the improvement in the conventional cohort (17.8, P= .151). Among patients who had both preoperative and 3-month postoperative HOOS, JR. scores, the mean improvement in HOOS, JR. at the 3-month postoperative interval was also greatest in the roboticcohort (29.8); this was significantly greater than the improvementsin both the conventional (24.6, P= .015) and navigation (23.8, P= .005) cohorts. For full reporting of scores at each time point, see Table8.
Table8
HOOS, JR. and PROMIS pain interference scores.
Variable | Conventional (n= 535) | Navigation (n= 1051) | Robotic (n= 113) | P-value |
---|---|---|---|---|
HOOS, JR. (preoperative) | 48.5 | 48.9 | 47.1 | .395 |
HOOS, JR. (6 wk) | 66.3 | 65.3 | 67.4 | .168 |
Delta HOOS, JR. (6 wk preoperative) | 17.8 | 16.4 | 20.3 | .034 |
Open in a separate window
Variable | Conventional (n= 586) | Navigation (n= 728) | Robotic (n= 73) | P-value |
---|---|---|---|---|
HOOS, JR. (preoperative) | 49.0 | 48.9 | 44.5 | .029 |
HOOS, JR. (3 mo) | 73.6 | 72.7 | 74.3 | .441 |
Delta HOOS, JR. (3 mo preoperative) | 24.6 | 23.8 | 29.8 | .018 |
Open in a separate window
Variable | Conventional (n= 657) | Navigation (n= 1248) | Robotic (n= 132) | P-value |
---|---|---|---|---|
PROMIS interference (preoperative) | 64.5 | 64.5 | 67.6 | <.001 |
PROMIS interference (6 wk) | 58.7 | 59.7 | 60.7 | .003 |
Delta PROMIS interference (6 wk preoperative) | −5.8 | −4.8 | −6.9 | .002 |
Open in a separate window
Variable | Conventional (n= 783) | Navigation (n= 986) | Robotic (n= 93) | P-value |
---|---|---|---|---|
PROMIS interference (preoperative) | 64.4 | 64.5 | 67.8 | <.001 |
PROMIS interference (3 mo) | 54.3 | 54.7 | 55.4 | .429 |
Delta PROMIS interference (3 mo preoperative) | −10.1 | −9.8 | −12.4 | .025 |
Open in a separate window
All bold P-values are statistically significant (P < .05).
Among patients who had both preoperative and 6-week postoperative PROMIS Pain Interference scores, the mean improvement in PROMIS Pain Interference scores at the 6-week postoperative interval was greatest in the robotic cohort (−6.9), which was significantly greater than the mean improvement found in the navigation cohort (−4.8, P= .005). The improvement between the preoperative and 6-week postoperative PROMIS scores in the conventional cohort was also significantly greater than that in the navigation cohort (−5.8 vs−4.8, P= .009). Among patients who had both preoperative and 3-month postoperative PROMIS Pain Interference scores, the difference between these preoperative and 3-month postoperative scores was that the robotic cohort again had the greatest improvement in PROMIS scores (−12.4), which was significantly greater than the improvement in both the conventional (−10.1, P= .020) and navigation (−9.8, P= .007) cohorts. For full reporting of scores at each time point, see Table8.
Discussion
The existing literature yields conflicting evidence on the effect of technology utilization in THA on clinical and patient-reported outcomes. The aim of our study was to investigate the effect of computer navigation and robotic assistance in pTHA on clinical and patient-reported outcomes in the first 90 days following surgery. We found that both short-term clinical and patient-reported outcomes were superior when robotic assistance was utilized. Our primary outcome, the postoperative day on which a perfect AM-PAC score was achieved, was the earliest in the robotic cohort, demonstrating that patients who underwent pTHA with robotic assistance had faster immediate postoperative functional recovery compared to patients who underwent pTHA with navigation or traditional instrumentation. Our other primary outcome, HOOS, JR. and PROMIS Pain Interference scores, also showed the greatest improvement at both 6 weeks and 3 months after surgery in the robotic cohort. These findings demonstrate that patients also subjectively experienced greater improvement when robotic assistance was utilized in pTHA.
AM-PAC scores were examined in this study as a proxy for immediate functional recovery following surgery. When assessing patients who underwent THA with robotic assistance, the greatest percentage of these patients achieved a perfect AM-PAC score on postoperative day 0. In contrast, the greatest percentage of patients in the conventional and navigation cohorts achieved a perfect AM-PAC score on postoperative day 1. Of the 3 cohorts, the robotic cohort was found to have the highest mean AM-PAC score on postoperative day 0, and on average, achieved a perfect AM-PAC score the earliest. To our knowledge, this is the first study using AM-PAC scores to compare the recovery between types of intraoperative technology in THA. The AM-PAC score analysis favored the use of robotic assistance in pTHA, with higher early scores in this cohort indicating more rapid functional improvement among these patients. Further research is needed to confirm the generalizability of this finding to other groups of patients and surgeons. If confirmed by further research, a possible explanation for faster recovery of function with robotic assistance could be better restoration of hip center of rotation, leg length, and offset, resulting in decreased soft tissue strain, decreased pain, and improved functional recovery. Furthermore, robotic guidance may reduce soft tissue dissection and require less retraction, since direct simultaneous visualization of the entire acetabulum is not needed for accurate implant placement. Decreased soft tissue trauma could potentially lead to a faster functional recovery.
Other clinical outcomes that favored the robotic cohort included length of stay in the hospital following surgery and readmission rate in the first 90 days following surgery. Mean lengths of stay were the shortest in the robotic cohort, and the use of robotics increased the odds of having a length of stay less than 24 hours. Additionally, the number of readmissions within the first 90 days was lower in the robotic cohort compared to the conventional and navigation cohorts. In a PearlDiver database study comparing the use of robotic-assisted THA to conventional THA, Remily etal. also found shorter lengths of stay with robotic-assisted THA but found no difference in readmission rates between the robotic and conventional cohorts at 90 days [14]. A potential advantage of the PearlDiver database is its ability to capture readmissions outside the institution where surgery was performed. Compared to database studies, an advantage of our single-institution study was the ability to access patient medical records, allowing more accurate and complete reporting of reasons for readmissions. The study by Remily etal. did not report reasons for readmission.
Other studies have also failed to find a significantly lower readmission rate with the use of robotic assistance in THA [15,16]. An earlier study from our center by Singh etal. [15] did not find a lower readmission rate in the robotic cohort. Of note, the study did not control for the year that the surgery was performed, which can independently impact various clinical outcomes. That study was also performed over an earlier time period and included far fewer cases with technology assistance, including 135 robotic surgery patients vs 1107 robotic surgery patients in the current study. Robotic assistance was also newer to our institution over the earlier time period, and there may be a learning curve before technology use reduces readmission rates. In a separate study by Shaw etal., which also failed to show a difference in readmission rates between robotic and manual THAs, 2 surgeons performed the robotic THAs. The greater number of surgeons in our study using robotics in THA helped increase our power by generating more cases and increasing the external validity of our findings, making them more likely to generalize to the practices of other surgeons. Nevertheless, because some of our results do contrast with previous literature, further studies are necessary to confirm or refute our findings.
The rate of dislocation requiring revision surgery within the first 90 days following index surgery was lowest in the robotic cohort. Although this finding did not reach statistical significance with the numbers available, the observed decrease from a 0.3% dislocation rate in the conventional group to a 0% dislocation rate in the robotic cohort would be clinically important if confirmed in larger studies with increased power. Previous studies have demonstrated similar results when comparing the rate of dislocation between robotically assisted and manual THA [17,18]. Bendich etal. found decreased odds of dislocation requiring reoperation within 1year in robot-assisted THA when compared to manual THA when a posterior approach is used [19]. In contrast, a meta-analysis of 17 studies by Ng etal. showed no difference in dislocation between robot-assisted and manual THA [20]. Bendich etal. included a larger robotic cohort with longer follow-up and, as a result, had greater power to find a difference in dislocation rates. As has been postulated in the literature, lower dislocation rates with the use of robotics could occur as the result of more accurate and precise cup placement. The current robotic platform does not simply enable more cups to be placed in the Lewinnek’s safe zone [21], but it also allows individualized targeting of component position based on 3D anatomy and functional spinopelvic planning. Formal spinopelvic planning was introduced during the study period, but its impact cannot be assessed using the data available in the current study.
The present study demonstrated the greatest increase in HOOS, JR. scores among patients who underwent robot-assisted pTHA. The improvement in score at 6 weeks following surgery by over 20 points and just under 30 points at 3 months following surgery exceed the minimum clinically important difference for HOOS, JR. scores, which has been reported to be 18.0 in a recent study [22]. While the differences from preoperative to postoperative scores in the robotic cohort were clinically significant, the differences in HOOS, JR. score improvement between cohorts did not exceed the reported minimum clinically important difference. Similar to HOOS, JR. scores, patients in the robotic cohort also demonstrated the greatest improvement in PROMIS Pain Interference scores at both 6 weeks and 3 months following surgery. This notable improvement in PROMs in the short-term postoperative period provides further evidence that patients who underwent pTHA with robotic assistance achieved superior short-term outcomes compared to patients who underwent pTHA with navigation or no technology. As with AM-PAC scores, the improvements in patients’ pain and perceived outcome in the robot-assisted cohort may be due in part to improved leg length discrepancy and offset, leading to less soft tissue strain. The reasons behind improved PROMs in the robotic cohort are unclear, and further investigation of the association between PROMs and technology in THA is warranted.
While prior studies have demonstrated good short-term patient-reported outcomes following robot-assisted THA, some did not directly compare these outcomes to those of manual THA [11,23]. Lu etal. assessed PROMs at 3 months postoperatively with Harris and Western Ontario and McMaster University Osteoarthritis index scores and found no significant differences between the robotic and manual THA groups [24]. Fontalis etal. assessed PROMs between robotic and conventional THA using the Oxford Hip Score, University of California at Los Angeles score, and Forgotten Joint Score and found no significant difference between the 2 cohorts for any of these scores. Conversely, Clement etal. found a statistically but not clinically significant improvement in the Oxford Hip Score in robotic THA when compared to manual THA, and the Forgotten Joint Score showed an improvement in robotic over manual THA that was both statistically and clinically significant [25]. From our center, Singh etal. also compared HOOS, JR. scores between robotic and conventional THA and found a significant improvement in the robotic cohort at 1year. They did not measure improvement from baseline to 90 days in their study, although they did not find any significant differences in raw 3-month scores between their 3 cohorts (manual, navigation, and robotic). Their robotic cohort of 135 cases was slightly larger than our cohort of 73 robotic THA patients who completed both a preoperative and 3-month postoperative HOOS, JR. score, and this difference may have been due to different selection criteria between the 2 studies. Nevertheless, their slightly larger robotic cohort may have decreased their risk of type II error. The lack of consensus in the literature, along with the addition of our results, demonstrates the innate variability of different PROMs as an outcome measure. While our findings contribute to the existing literature by challenging many of the previous findings on the impact of robotic THA on short-term PROMs, further studies examining HOOS, JR. and PROMIS scores in robotic THA are necessary.
Limitations
This retrospective observational study has important limitations. Because this study is retrospective, it is subject to collection error. Additionally, the sample size of the robotic cohort, especially the subset with PROMs data, was relatively limited in comparison to the sample sizes of the navigation and conventional cohorts. Because this data was collected from a single institution, reported outcomes are limited to those that occurred within our institution. While the purpose of this study was to examine the outcomes of technology use in pTHA in the short term, the lack of long-term follow-up in this study limits the conclusions that can be drawn about the long-term impact of technology use in THA on clinical and patient-reported outcomes, along with implant durability. To address this, additional studies with greater follow-up are warranted to better understand the long-term benefit of technology use in THA on the patient. Despite these limitations, our results add to the existing literature by demonstrating improved short-term outcomes with the use of robotic assistance in pTHA, which will hopefully lead to further exploration into the potential benefits of robotic assistance in THA.
Conclusions
The use of robotic assistance in pTHA showed superior clinical and patient reported outcomes in the first 90 days following surgery when compared to the use of navigation or traditional instrumentation alone. These findings have not been consistently reported in the current literature on this topic and should inspire further investigation. Additional studies with greater follow-up are necessary to understand whether the short-term benefits of robotic use in THA found in this study are confirmed in other clinical settings and translate to a long-term impact on clinical and patient reported outcomes.
Conflicts of interest
M. Hepinstall is a speaker for Stryker, is a paid consultant and receives research support from Exactech and Stryker, and is a board/committee member of AAOS, AAHKS, CAOS, and ISTA. M. Meftah receives royalties from Innomed, is a paid consultant for Conformis and Intellijoint, has stock options in CAIRA Surgical and Constance, is an editorial/governing board member of Orthopedics, and is a board/committee member of ISTA. P. Meere receives royalties from Stryker, has stock options in Intellijoint and Stryker, and is an editorial board member of the Bulletin for Joint Diseases. All other authors declare no potential conflicts of interest.
For full disclosure statements refer to https://doi.org/10.1016/j.artd.2024.101393.
CRediT authorship contribution statement
Alana Prinos: Formal analysis, Writing – original draft, Writing – review & editing. Weston Buehring: Data curation, Writing – original draft. Catherine Di Gangi: Data curation, Formal analysis. Patrick Meere: Writing – review & editing. Morteza Meftah: Writing – review & editing. Matthew Hepinstall: Conceptualization, Methodology, Project administration, Supervision, Writing – review & editing.
Appendix A. Supplementary Data
Conflict of Interest Statement for Prinos:
Click here to view.(17K, docx)
Conflict of Interest Statement for Di Gangi:
Click here to view.(17K, docx)
Conflict of Interest Statement for Hepinstall:
Click here to view.(17K, docx)
Conflict of Interest Statement for Meftah:
Click here to view.(17K, docx)
Conflict of Interest Statement for Meere:
Click here to view.(17K, docx)
Conflict of Interest Statement for Buehring:
Click here to view.(17K, docx)
Appendix
1.
What is the primary outcome of this study?
a.
Readmission rate
b.
Dislocation rate
c.
Perfect AM-PAC score achievement
d.
PROMs
e.
c and d
Correct answer: e
The primary outcomes of this study were the mean day on which a perfect AM-PAC score was achieved and improvement in HOOS, JR. and PROMIS Pain Interference scores. Patients undergoing robot-assisted THA achieved a perfect AM-PAC score earliest on average, and patients in this cohort had the greatest improvements in PROMs at both 6 weeks and 3 months following surgery.
2.
By what magnitude did robot-assisted surgery increase the odds of length of stay being less than 24 hours?
a.
1.7
b.
2.4
c.
2.7
d.
3.1
e.
3.8
Correct answer: b
Robot-assisted THA was associated with 2.4 times the odds of having a length of stay less than 24 hours when compared to no technology use in THA. This increase in odds was statistically significant (P < .001).
3.
How many dislocations requiring revision surgery occurred in the robotic cohort within the first 90 days following index surgery?
a.
b.
2
c.
4
d.
6
e.
8
Correct answer: a
There were no dislocations that required revision surgery within the first 90 days following index surgery. This was less than the 13 and 16 dislocations requiring revision in the navigation and conventional cohorts, respectively. None of the differences between the 3 cohorts were found to be statistically significant.
References
1. Learmonth I.D., Young C., Rorabeck C. The operation of the century: total hip replacement. Lancet. 2007;370:1508–1519. doi:10.1016/S0140-6736(07)60457-7. [PubMed] [CrossRef] [Google Scholar]
2. Sloan M., Premkumar A., Sheth N.P. Projected volume of primary total joint arthroplasty in the u.s., 2014 to 2030. JBone Joint Surg Am. 2018;100:1455–1460. doi:10.2106/JBJS.17.01617. [PubMed] [CrossRef] [Google Scholar]
3. Healy W.L., Iorio R., Clair A.J., Pellegrini V.D., Della Valle C.J., Berend K.R. Complications of total hip arthroplasty: standardized list, definitions, and stratification developed by the hip society. Clin Orthop Relat Res. 2016;474:357–364. doi:10.1007/S11999-015-4341-7. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Emara A.K., Samuel L.T., Acuña A.J., Kuo A., Khlopas A., Kamath A.F. Robotic-arm assisted versus manual total hip arthroplasty: systematic review and meta-analysis of radiographic accuracy. Int J Med Robot. 2021;17 doi:10.1002/RCS.2332. [PubMed] [CrossRef] [Google Scholar]
5. Hepinstall M., Zucker H., Matzko C., Meftah M., Mont M.A. Adoption of robotic arm-assisted total hip arthroplasty results in reliable clinical and radiographic outcomes at minimum two-year follow up. Surg Technol Int. 2021;38:440–445. doi:10.52198/21.STI.38.OS1420. [PubMed] [CrossRef] [Google Scholar]
6. Domb B.G., El Bitar Y.F., Sadik A.Y., Stake C.E., Botser I.B. Comparison of robotic-assisted and conventional acetabular cup placement in THA: a matched-pair controlled study hip. Clin Orthop Relat Res. 2014;472:329–336. doi:10.1007/s11999-013-3253-7. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. Sugano N. Computer-assisted orthopaedic surgery and robotic surgery in total hip arthroplasty. Clin Orthop Surg. 2013;5:1–9. doi:10.4055/CIOS.2013.5.1.1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
8. Snijders T., van Gaalen S.M., de Gast A. Precision and accuracy of imageless navigation versus freehand implantation of total hip arthroplasty: a systematic review and meta-analysis. Int J Med Robot. 2017;13:1–7. doi:10.1002/RCS.1843. [PubMed] [CrossRef] [Google Scholar]
9. Perets I., Walsh J.P., Mu B.H., Mansor Y., Rosinsky P.J., Maldonado D.R., et al. Short-term clinical outcomes of robotic-arm assisted total hip arthroplasty: a pair-matched controlled study. Orthopedics. 2021;44:E236–E242. doi:10.3928/01477447-20201119-10. [PubMed] [CrossRef] [Google Scholar]
10. Kort N., Stirling P., Pilot P., Müller J.H. Clinical and surgical outcomes of robot-assisted versus conventional total hip arthroplasty: a systematic overview of meta-analyses. EFORT Open Rev. 2021;6:1157–1165. doi:10.1302/2058-5241.6.200121. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
11. Perets I., Walsh J.P., Close M.R., Mu B.H., Yuen L.C., Domb B.G. Robot-assisted total hip arthroplasty: clinical outcomes and complication rate. Int J Med Robot. 2018;14 doi:10.1002/RCS.1912. [PubMed] [CrossRef] [Google Scholar]
12. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. Anew method of classifying prognostic comorbidity in longitudinal studies: development and validation. JChronic Dis. 1987;40:373–383. doi:10.1016/0021-9681(87)90171-8. [PubMed] [CrossRef] [Google Scholar]
13. Hadad M.J., Orr M.N., Emara A.K., Klika A.K., Johnson J.K., Piuzzi N.S. PLAN and AM-PAC “6-clicks” scores to predict discharge disposition after primary total hip and knee arthroplasty. JBone Joint Surg Am. 2022;104:326–335. doi:10.2106/JBJS.21.00503. [PubMed] [CrossRef] [Google Scholar]
14. Remily E.A., Nabet A., Sax O.C., Douglas S.J., Pervaiz S.S., Delanois R.E. Impact of robotic assisted surgery on outcomes in total hip arthroplasty. Arthroplast Today. 2021;9:46–49. doi:10.1016/j.artd.2021.04.003. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
15. Singh V., Realyvasquez J., Simcox T., Rozell J.C., Schwarzkopf R., Davidovitch R.I. Robotics versus navigation versus conventional total hip arthroplasty: does the use of technology yield superior outcomes? JArthroplasty. 2021;36:2801–2807. doi:10.1016/J.ARTH.2021.02.074. [PubMed] [CrossRef] [Google Scholar]
16. Shaw J.H., Rahman T.M., Wesemann L.D., Jiang C.Z., Lindsay-Rivera K.G., Davis J.J. Comparison of postoperative instability and acetabular cup positioning in robotic-assisted versus traditional total hip arthroplasty. JArthroplasty. 2022;37:S881–S889. doi:10.1016/j.arth.2022.02.002. [PubMed] [CrossRef] [Google Scholar]
17. Illgen R.L., Bukowski B.R., Abiola R., Anderson P., Chughtai M., Khlopas A., et al. Robotic-assisted total hip arthroplasty: outcomes at minimum two-year follow-up. Surg Technol Int. 2017;30:365–372. [PubMed] [Google Scholar]
18. Maldonado D.R., Go C.C., Kyin C., Rosinsky P.J., Shapira J., Lall A.C., et al. Robotic arm-assisted total hip arthroplasty is more cost-effective than manual total hip arthroplasty: a markov model analysis. JAm Acad Orthop Surg. 2021;29:E168–E177. doi:10.5435/JAAOS-D-20-00498. [PubMed] [CrossRef] [Google Scholar]
19. Bendich I., Vigdorchik J.M., Sharma A.K., Mayman D.J., Sculco P.K., Anderson C., et al. Robotic assistance for posterior approach total hip arthroplasty is associated with lower risk of revision for dislocation when compared to manual techniques. JArthroplasty. 2022;37:1124–1129. doi:10.1016/J.ARTH.2022.01.085. [PubMed] [CrossRef] [Google Scholar]
20. Ng N., Gaston P., Simpson P.M., Macpherson G.J., Patton J.T., Clement N.D. Robotic arm-assisted versus manual total hip arthroplasty : a systematic review and meta-analysis. Bone Joint J. 2021;103-B:1009–1020. doi:10.1302/0301-620X.103B6.BJJ-2020-1856.R1. [PubMed] [CrossRef] [Google Scholar]
21. Domb B.G., El Bitar Y.F., Sadik A.Y., Stake C.E., Botser I.B. Comparison of robotic-assisted and conventional acetabular cup placement in THA: a matched-pair controlled study. Clin Orthop Relat Res. 2014;472:329–336. doi:10.1007/S11999-013-3253-7. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
22. Hung M., Bounsanga J., Voss M.W., Saltzman C.L. Establishing minimum clinically important difference values for the Patient-Reported Outcomes Measurement Information System Physical Function, hip disability and osteoarthritis outcome score for joint reconstruction, and knee injury and osteoarthritis outcome score for joint reconstruction in orthopaedics. World J Orthop. 2018;9:41–49. doi:10.5312/wjo.v9.i3.41. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. Wang Y., Ji B., Chen Y., Li G. [Short-term effectiveness of MAKO robot assisted complex total hip arthroplasty] Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022;36:555–560. doi:10.7507/1002-1892.202109054. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
24. Lu H., Sun H., Xiao Q., Xu H., Zhou Q., Li L., et al. Perioperative safety and efficacy of robot-assisted total hip arthroplasty in ERAS-managed patients: a pilot study. JOrthop Surg Res. 2023;18:696. doi:10.1186/S13018-023-04180-Y. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
25. Clement N.D., Gaston P., Bell A., Simpson P., Macpherson G., Hamilton D.F., et al. Robotic arm-assisted versus manual total hip arthroplasty: a propensity score matched cohort study. Bone Joint Res. 2021;10:22. doi:10.1302/2046-3758.101.BJR-2020-0161.R1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Articles from Arthroplasty Today are provided here courtesy of Elsevier